In a previous study, the CBX7 overexpression has been associated with the poor prognosis of the ovarian adenocarcinomas through inhibiting the TRAIL-induced apoptotic pathway, suggesting the carcinogenic effects of CBX7 [8]. The gene discussed is TNFSF10; the disease is ovarian adenocarcinoma.